Airsculpt Technologies Inc (AIRS)vsDaVita HealthCare Partners Inc (DVA)
AIRS
Airsculpt Technologies Inc
$3.05
+8.16%
HEALTHCARE · Cap: $165.46M
DVA
DaVita HealthCare Partners Inc
$155.11
+1.19%
HEALTHCARE · Cap: $10.25B
Smart Verdict
WallStSmart Research — data-driven comparison
DaVita HealthCare Partners Inc generates 8559% more annual revenue ($13.64B vs $157.55M). DVA leads profitability with a 5.5% profit margin vs -11.4%. DVA earns a higher WallStSmart Score of 66/100 (B-).
AIRS
Hold40
out of 100
Grade: F
DVA
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AIRS.
Margin of Safety
+11.7%
Fair Value
$163.40
Current Price
$155.11
$8.29 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Every $100 of equity generates 65 in profit
Growing faster than its price suggests
Attractively priced relative to earnings
Areas to Watch
2.0% earnings growth
Smaller company, higher risk/reward
Elevated debt levels
Weak financial health signals
5.5% margin — thin
Weak financial health signals
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AIRS
The strongest argument for AIRS centers on Price/Book.
Bull Case : DVA
The strongest argument for DVA centers on Return on Equity, PEG Ratio, P/E Ratio. PEG of 0.56 suggests the stock is reasonably priced for its growth.
Bear Case : AIRS
The primary concerns for AIRS are EPS Growth, Market Cap, Debt/Equity.
Bear Case : DVA
The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.
Key Dynamics to Monitor
AIRS profiles as a turnaround stock while DVA is a value play — different risk/reward profiles.
AIRS carries more volatility with a beta of 2.80 — expect wider price swings.
DVA is growing revenue faster at 9.9% — sustainability is the question.
DVA generates stronger free cash flow (395M), providing more financial flexibility.
Bottom Line
DVA scores higher overall (66/100 vs 40/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Airsculpt Technologies Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Airsculpt Technologies Inc (AIRS) is at the forefront of the aesthetic medical technology sector, renowned for its innovative AirSculpt® procedure, which provides minimally invasive body contouring solutions. The company prioritizes patient safety and comfort while delivering remarkable aesthetic outcomes, thereby transforming the cosmetic surgery experience. With a robust network of licensed practitioners and a strong commitment to technological advancement, Airsculpt is strategically positioned to capitalize on the increasing global demand for non-invasive cosmetic procedures, aiming to enhance its market presence and diversify its offerings. This proactive approach not only drives immediate growth but also sets the foundation for sustainable long-term value creation for its investors.
Visit Website →DaVita HealthCare Partners Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?